These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32910125)

  • 41. Tailoring Platinum(IV) Amphiphiles for Self-Targeting All-in-One Assemblies as Precise Multimodal Theranostic Nanomedicine.
    He S; Li C; Zhang Q; Ding J; Liang XJ; Chen X; Xiao H; Chen X; Zhou D; Huang Y
    ACS Nano; 2018 Jul; 12(7):7272-7281. PubMed ID: 29906087
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oxidative Stress Induced by Pt(IV) Pro-drugs Based on the Cisplatin Scaffold and Indole Carboxylic Acids in Axial Position.
    Tolan D; Gandin V; Morrison L; El-Nahas A; Marzano C; Montagner D; Erxleben A
    Sci Rep; 2016 Jul; 6():29367. PubMed ID: 27404565
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structural and anticancer properties of hydrogen bonded diphenyl phosphate adducts of Pt(IV) complexes: the importance of pKa matching.
    Failes TW; Battle AR; Chen C; Cullinane C; Woods R; Elliott R; Deacon GB; Hambley TW
    J Inorg Biochem; 2012 Oct; 115():220-5. PubMed ID: 22658243
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human Serum Albumin Conjugated Nanoparticles for pH and Redox-Responsive Delivery of a Prodrug of Cisplatin.
    Shi H; Cheng Q; Yuan S; Ding X; Liu Y
    Chemistry; 2015 Nov; 21(46):16547-54. PubMed ID: 26405808
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Supramolecular platinum complexes for cancer therapy.
    Jogadi W; Zheng YR
    Curr Opin Chem Biol; 2023 Apr; 73():102276. PubMed ID: 36878171
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and Cytotoxic Study of a Platinum(IV) Anticancer Prodrug with Selectivity toward Luteinizing Hormone-Releasing Hormone (LHRH) Receptor-Positive Cancer Cells.
    Yao H; Xu Z; Li C; Tse MK; Tong Z; Zhu G
    Inorg Chem; 2019 Aug; 58(16):11076-11084. PubMed ID: 31393117
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mono- and di-bromo platinum(IV) prodrugs via oxidative bromination: synthesis, characterization, and cytotoxicity.
    Xu Z; Wang Z; Yiu SM; Zhu G
    Dalton Trans; 2015 Dec; 44(46):19918-26. PubMed ID: 26514681
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stability, Reduction, and Cytotoxicity of Platinum(IV) Anticancer Prodrugs Bearing Carbamate Axial Ligands: Comparison with Their Carboxylate Analogues.
    Chen S; Yao H; Zhou Q; Tse MK; Gunawan YF; Zhu G
    Inorg Chem; 2020 Aug; 59(16):11676-11687. PubMed ID: 32799457
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The new antitumor compound, cis-[Pt(NH3)2(4-methylpyridine)Cl]Cl, does not form N7,N7-d(GpG) chelates with DNA. An unexpected preference for platinum binding at the 5'G in d(GpG).
    Lempers EL; Bloemink MJ; Brouwer J; Kidani Y; Reedijk J
    J Inorg Biochem; 1990 Sep; 40(1):23-35. PubMed ID: 2283508
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immuno-chemotherapeutic platinum(IV) prodrugs of cisplatin as multimodal anticancer agents.
    Wong DY; Yeo CH; Ang WH
    Angew Chem Int Ed Engl; 2014 Jun; 53(26):6752-6. PubMed ID: 24844571
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Ratiometric Fluorescent Probe for Cisplatin: Investigating the Intracellular Reduction of Platinum(IV) Prodrug Complexes.
    Ong JX; Lim CSQ; Le HV; Ang WH
    Angew Chem Int Ed Engl; 2019 Jan; 58(1):164-167. PubMed ID: 30407697
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes.
    Choi S; Vastag L; Larrabee YC; Personick ML; Schaberg KB; Fowler BJ; Sandwick RK; Rawji G
    Inorg Chem; 2008 Feb; 47(4):1352-60. PubMed ID: 18220340
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Corrosion-Activated Chemotherapeutic Function of Nanoparticulate Platinum as a Cisplatin Resistance-Overcoming Prodrug with Limited Autophagy Induction.
    Cheng HJ; Wu TH; Chien CT; Tu HW; Cha TS; Lin SY
    Small; 2016 Nov; 12(44):6124-6133. PubMed ID: 27717137
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multi-action Pt(IV) anticancer agents; do we understand how they work?
    Gibson D
    J Inorg Biochem; 2019 Feb; 191():77-84. PubMed ID: 30471522
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification and Directed Development of Non-Organic Catalysts with Apparent Pan-Enzymatic Mimicry into Nanozymes for Efficient Prodrug Conversion.
    Walther R; Winther AK; Fruergaard AS; van den Akker W; Sørensen L; Nielsen SM; Jarlstad Olesen MT; Dai Y; Jeppesen HS; Lamagni P; Savateev A; Pedersen SL; Frich CK; Vigier-Carrière C; Lock N; Singh M; Bansal V; Meyer RL; Zelikin AN
    Angew Chem Int Ed Engl; 2019 Jan; 58(1):278-282. PubMed ID: 30408323
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dinuclear platinum anticancer complexes with fluorescent N,N'-bis(aminoalkyl)-1,4-diaminoanthraquinones: cellular processing in two cisplatin-resistant cell lines reflects the differences in their resistance profiles.
    Kalayda GV; Jansen BA; Wielaard P; Tanke HJ; Reedijk J
    J Biol Inorg Chem; 2005 May; 10(3):305-15. PubMed ID: 15824924
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs.
    Ravera M; Gabano E; Zanellato I; Bonarrigo I; Alessio M; Arnesano F; Galliani A; Natile G; Osella D
    J Inorg Biochem; 2015 Sep; 150():1-8. PubMed ID: 26042542
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cellular accumulation and DNA platination of two new platinum(II) anticancer compounds based on anthracene derivatives as carrier ligands.
    Marqués-Gallego P; Kalayda GV; Jaehde U; Dulk Hd; Brouwer J; Reedijk J
    J Inorg Biochem; 2009 May; 103(5):791-6. PubMed ID: 19303143
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ctc-[Pt(NH
    Li Y; Shi S; Zhang S; Gan Z; Wang X; Zhao X; Zhu Y; Cao M; Wang X; Li W
    Dalton Trans; 2021 Aug; 50(32):11180-11188. PubMed ID: 34338267
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Investigation of the Inertness to Hydrolysis of Platinum(IV) Prodrugs.
    Ritacco I; Mazzone G; Russo N; Sicilia E
    Inorg Chem; 2016 Feb; 55(4):1580-6. PubMed ID: 26812023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.